HIV infection and surgeons

Current Problems in Surgery

Volumn 29, Issue 4, 1992, Pages 207-280

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; OCCUPATIONAL DISEASE; PATIENT; REVIEW; SERODIAGNOSIS; SURGERY; UNITED STATES; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; SURGEON;

AIDS SERODIAGNOSIS; HEALTH PERSONNEL; HIV INFECTIONS; HUMAN; INCIDENCE; OCCUPATIONAL DISEASES; PATIENTS; SURGERY; UNITED STATES;

EID: 0026847454     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1016/0011-3840(92)90007-P     Document Type: Article

References (189)

1. Pneumocystis pneumonia—Los Angeles
2. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy men: Evidence of a new acquired cellular immunodeficiency
3. Kaposi sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California
4. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
5. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS pre-AIDS
6. The true source of HIV?
7. Recommendations for preventing transmission of infection with human T-lymphotrophic virus type III/lymphoadenopathy-associated virus in the workplace
8. Recommendations for preventing transmission of infection with human T-lymphotrophic virus type III/lymphoadenopathy-associated virus in the workplace
9. Recommendations for preventing transmission of infection with T-lymphotrophic virus type III/lymphoadenopathy-associated virus during invasive procedures
10. Recommendations for prevention of HIV transmission in health-care settings
11. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
12. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis of Pneumocystis carinii pneumonia in AIDS
13. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter
14. Possible transmission of human immunodeficiency virus to a patient during an invasive dental procedure
15. Update: Transmission of HIV infection during an invasive dental procedure—Florida
16. The HIV/AIDS epidemic: The first 10 years
17. The HIV/AIDS epidemic: The first 10 years
18. Estimates of HIV prevalence and projected AIDS cases
19. HIV-2 in perspective
20. Chemotherapy of human immunodeficiency virus infections: Current practice and future prospects
21. Seropositivity for HIV and the development of AIDS or ARC
22. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men
23. Three year incidence of AIDS in five cohorts of HTLV III infected risk group members
24. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia
25. Acute AIDS retrovirus infection: Definition of a clinical illness associated with seroconversion
26. Characteristics of the acute clinical illness associated with human immunodeficiency virus infection
27. Acute myelopathy associated with primary infection with primary infection with human immunodeficiency virus
28. Acute illnesses associated with HTLV III seroconversion
29. Antibody response to human immunodeficiency virus after primary infection
30. Quantitation of human immunodeficiency virus type 1 in blood of infected persons
31. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
32. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures
33. Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic Western blot
34. HIV-1 in seronegative homosexual men
35. From persistent generalized lymphadenopathy to AIDS: Who will progress?
36. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection
37. Loss of Human Immunodeficiency Virus Type 1 (HIV-I) Antibodies with Evidence of Viral Infection in Asymptomatic Homosexual Men
38. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
39. Acquired immunodeficiency syndrome (AIDS)
40. The Walter Reed staging classification in the follow-up of HIV infection
41. Statistical modeling of the AIDS epidemic for forecasting health care needs
42. CD 4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men
43. CD4 counts as predicators of opportunistic pneumonias in human immunodeficiency in virus infected individuals
44. Predicting the progression to AIDS
45. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use
46. Pneumocystis pneumonia: From bench to clinic
47. Dissemination infection with Mycobacterium avium-intracellulare
48. Tuberculosis in patients with human immunodeficiency virus infection
49. AIDS-associated non-Hodgkins lymphoma in San Francisco
50. The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco
51. The acquired immunodeficiency syndrome (AIDS) dementia complex
52. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection
53. AIDS vaccines: Progress and unmet challenges
54. AIDS hysteria goes on 10 years
55. HIV infection in Manchester, 1959 (letter)
56. Evidence for human infection with an HTLV III/LAV-like virus in central Africa
57. Documentation of an AIDS Virus Infection in the United States in 1968
58. Epidemiology of HIV infection and AIDS in the United States
59. Reconstruction and future trends of the AIDS epidemic in the U.S.
60. HIV prevalence estimates and AIDS care projections for the U.S.
61. AIDS: An international perspective
62. The sobering geography of AIDS
63. Epidemiology of women with AIDS in the United States, 1981 through 1990
64. AIDS—The leading cause of death in the West African city of Abidjan, Ivory Coast
65. Vertical transmission of HIV.
66. The risk of transmission of HIV-1 through non-percutaneous non-sexual modes—A review
67. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study
68. Seroconversion, sexual activity and condom use among 2915 HIV seronegative men followed for up to 2 years
69. Prevalence of HIV infection among intravenous drug users in the United States
70. HIV-1 seroconversions in a cohort of intravenous drug users
71. Human T-lymphotrophic retrovirus type III/lymphadenopathy-associated virus antibody
72. Heterosexual human immunodeficiency virus transmission among the middle class
73. Heterosexual HIV transmission
74. Human immunodeficiency virus infection in sexually active wives of infected hemophiliac men
75. Female-to-male transmission of human immunodeficiency virus
76. Antibody to human immunodeficiency virus in female prostitutes
77. Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States
78. Prevalence of the human immunodeficiency virus among university students
79. Trends in human immunodeficiency virus infection among civilian applicants for military service—United States, October 1985–March 1988
80. Incidence of human immunodeficiency virus seroconversion in US Navy and Marine Corps personnel, 1986 through 1988
81. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections
82. Benefits and costs of HIV testing
83. The HIV testing policies of U.S. hospitals
84. AIDS and suicide
85. Suicidal ideation and HIV testing
86. Mandatory premarital testing for human immunodeficiency virus: The Illinois experience
87. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic
88. A Dual Approach to the AIDS Epidemic
89. Public health policy and the AIDS epidemic: An end to HIV exceptionalism?
90. The cause for wider use of testing for HIV infection
91. Transmission of the human immunodeficiency virus in the health care setting—Time for action
92. Preoperative screening for HIV infection
93. Routine preoperative screening for HIV: Does the risk to the surgeon outweigh the risk to the patient?
94. Preliminary analysis: HIV serosurvey of orthopedic surgeons
95. AIDS in the operating room
96. AIDS: The ethical dilemma for surgeons
97. Does knowledge of human immunodeficiency virus infection decrease the frequency of occupational exposure to blood?
98. Measurement of false positive rate in a screening program for human immunodeficiency virus infection
99. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody
100. Exposure of patients to human immunodeficiency virus through transfusion of blood components that test antibody-negative
101. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery
102. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells
103. Surveillance for HIV-2 infection in blood donors—United States, 1987–1989
104. Absence of HIV infection in blood donors with indeterminant Western blot tests for antibody to HIV-1
105. Human immunodeficiency virus infection and indeterminate Western blot patterns
106. Evaluation of two rapid screening assays for the detection of human immunodeficiency virus-1 infection in emergency department patients
107. Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals
108. A multicenter proficiency trial of gene amplification (PCR) for detection of HIV
109. Detection of human immunodeficiency virus type 1 in AIDS patients using amplification-mediated hybridization analyses: Reproductibility and quantitative limitations
110. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV infected individuals
111. Occupational risk of the acquired immunodeficiency syndrome among health care workers
112. Update: Human immunodeficiency virus infection in health care workers exposed to blood of infected patients
113. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health care settings
114. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health care settings
115. Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations
116. How much blood in a needle-stick?
117. Bloody needles: Volumes of blood transferred in simulations of needle-stick injuries and shared used of syringes for injection of intravenous drugs
118. Frequency of nonparenteral occupational exposure to blood and body fluids before and after universal precautions training
119. Rates of needle-stick injury caused by various devices in a university hospital
120. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissue and semen for evidence of hepatitis B and hepatitis C
121. Blood contacts during surgical procedures
122. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital
123. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health care and public safety workers
124. AIDS: The contamination risk in urologic surgery
125. Estimate of the Risk of Epidemic Transmission of Hepatitis B Virus and Human Immunodeficiency Virus to Patients by the Percutaneous Route During Invasive Surgical and Dental Procedures
126. Risk of surgeons: A survey of accidental injuries during operations
127. Epidemiology of hospital sharps injuries: A 14-year prospective study in the pre-AIDS and AIDS eras
128. Blood contacts during surgical procedures
129. Blood contact and exposure in the operating room
130. Human immunodeficiency virus transmission in health care settings: Risk and risk reduction
131. A survey of exposures, practices and recommendations of surgeons in the care of patients with human immunodeficiency virus
132. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures
133. Doctors and AIDS
134. Can more be done to protect operating room personnel
135. Enforcement Procedure for Occupational Exposure to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV)
136. Failure of educational programs, needles disposal containers and universal precautions to decrease needlestick injuries in health care workers
137. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine
138. Survival and Disinfectant Inactivation of the Human Immunodeficiency Virus: A Critical Review
139. Adherence to universal (barrier) precautions during interventions on critically ill and injured emergency department patients
140. Exposure of health care workers to blood during various procedures
141. Factors predicting infectivity following needlestick exposure in HIV: An in vitro model
142. Surgery and AIDS, reducing the risk
143. Rules and Regulations: Medical Gloves
144. Glove use and blood-hand contacts during surgical procedures
145. Barrier efficacy of surgical gowns
146. Unrecognized human immunodeficiency virus infection in emergency department patients
147. Prevalence of infection with human immunodeficiency virus in elective surgery patients
148. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine post-exposure use
149. The hepatitis B virus-infected health care worker
150. Prevalence and incidence of HIV, HCV and HSV serology among health care providers
151. Hepatitis C in hospital employees with needlestick injuries
152. Failure of zidovudine prophylaxis after accidental exposure to HIV-1
153. Failed prophylactic zidovudine after needlestick injury
154. Post-exposure zidovudine chemoprophylaxis for health care workers occupationally exposed to human immunodeficiency virus: An interim analysis
155. Postexposure prophylaxis with zidovudine suppress human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner
156. Suppression of HIV infection in AZT treated SCID-hu mice
157. Simian model of retrovirus chemoprophylaxis with constant infusion of zidovudine ± interferon alpha
158. Zidovudine post-exposure chemoprophylaxis for health care workers exposed to HIV at San Francisco General Hospital
159. Zidovudine use after occupational exposure to HIV-infected blood
160. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus type 1: Current status and prospects for the future
161. Update: Transmission of HIV infection during an invasive dental procedure—Florida
162. Update: Transmission of HIV infection during an invasive dental procedure—Florida
163. Update: Transmission of HIV infection during invasive dental procedure—Florida
164. Unreported findings shed new light on HIV dental care
165. Official tells of U.S. plan to discourage abortions.
166. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: Rate of sequence change and low frequency of inactivating mutations
167. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells
168. Transmission of HIV infection from surgeon to patient: Estimating the risk
169. Risk of transmission of HIV from surgeon to patient
170. Judge rules surgeon infected with AIDS virus must tell patients
171. Another approach to the AIDS epidemic
172. Large majorities continue to back AIDS testing—Growing compassion and tolerance found
173. The human immunodeficiency virus-infected health care worker
174. HIV infected providers losing jobs due to CDC guidelines
175. Expected costs of implementing a mandatory human immunodeficiency virus and hepatitis B virus testing and restriction program for healthcare workers performing invasive procedures
176. The Pennsylvania Department of Health's Bureau of HIV/AIDS recently calculated financial costs of health care workers
177. Baltimore judge dismisses suits on fear of AIDS
178. Mandatory testing of health care workers pose legal risks
179. Public health and the law: HIV antibody status and employment discrimination
180. AIDS commentary
181. A surgery with AIDS: Lack of evidence of transmission to patients
182. Management of patients treated by a surgeon with HIV infection
183. Investigation of a health care worker with symptomatic human immunodeficiency virus infection: An epidemiologic approach
184. HIV-1 in seronegative homosexual men